Abstract:To determine chemical-protein interactions (CPI) is costly, time-consuming, and labor-intensive. In silico prediction of CPI can facilitate the target identification and drug discovery. Although many in silico target prediction tools have been developed, few of them could predict active molecules against multitarget for a single disease. In this investigation, naive Bayesian (NB) and recursive partitioning (RP) algorithms were applied to construct classifiers for predicting the active molecules against 25 key targets toward Alzheimer's disease (AD) using the multitarget-quantitative structure-activity relationships (mt-QSAR) method. Each molecule was initially represented with two kinds of fingerprint descriptors (ECFP6 and MACCS). One hundred classifiers were constructed, and their performance was evaluated and verified with internally 5-fold cross-validation and external test set validation. The range of the area under the receiver operating characteristic curve (ROC) for the test sets was from 0.741 to 1.0, with an average of 0.965. In addition, the important fragments for multitarget against AD given by NB classifiers were also analyzed. Finally, the validated models were employed to systematically predict the potential targets for six approved anti-AD drugs and 19 known active compounds related to AD. The prediction results were confirmed by reported bioactivity data and our in vitro experimental validation, resulting in several multitarget-directed ligands (MTDLs) against AD, including seven acetylcholinesterase (AChE) inhibitors ranging from 0.442 to 72.26 μM and four histamine receptor 3 (H3R) antagonists ranging from 0.308 to 58.6 μM. To be exciting, the best MTDL DL0410 was identified as an dual cholinesterase inhibitor with IC50 values of 0.442 μM (AChE) and 3.57 μM (BuChE) as well as a H3R antagonist with an IC50 of 0.308 μM. This investigation is the first report using mt-QASR approach to predict chemical-protein interaction for a single disease and discovering highly potent MTDLs. This protocol may be useful for in silico multitarget prediction of other diseases.

Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching.

Feasibility of using molecular docking-based virtual screening for searching dual target kinase inhibitors

Design of Multitarget Ligands with an Iterative Fragment-Growing Strategy.

Computer Aided Multi-target Drug Design, Multi-target Virtual Screening

Multiple target-based pharmacophore design from active site structures

In-Silico Approaches to Multi-target Drug Discovery

Rapid identification of dual p53-MDM2/MDMX interaction inhibitors through virtual screening and hit-based substructure search

Discovery of Multitarget-Directed Ligands Against Alzheimer'S Disease Through Systematic Prediction of Chemical Protein Interactions

Effective Screening Strategy Using Ensembled Pharmacophore Models Combined with Cascade Docking: Application to P53-Mdm2 Interaction Inhibitors

Molecular hybridization: a powerful tool for multitarget drug discovery

Pharmacophore screening, molecular docking, ADMET prediction and MD simulations for identification of ALK and MEK potential dual inhibitors

Hierarchical Virtual Screening of the Dual MMP-2/HDAC-6 Inhibitors from Natural Products Based on Pharmacophore Models and Molecular Docking.

Rational Multitargeted Drug Design Strategy from the Perspective of a Medicinal Chemist

Predicting Targeted Polypharmacology for Drug Repositioning and Multi- Target Drug Discovery

Combined Multi-Pharmacophore, Molecular Docking and Molecular Dynamic Study for Discovery of Promising MTH1 Inhibitors

A Novel Strategy for Designing the Magic Shotguns for Distantly Related Target Pairs

Multiple-docking and affinity fingerprint methods for protein classification and inhibitors selection

Discovery of novel dual VEGFR2 and Src inhibitors using a multistep virtual screening approach

Large-Scale Target Identification of Herbal Medicine Using a Reverse Docking Approach

Discovery of selective ACAT2 antagonist via a combination strategy based on deep docking, pharmacophore modelling, and molecular dynamics simulation

Rational Design of Multi-Target-Directed Ligands: Strategies and Emerging Paradigms.